Micronose Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Micronose General Information
Description
Developer of a natural intranasal allergy therapy intended to restore immune balance in the respiratory tract. The company offers intranasal probiotic sprays, anti-allergy formulations, personalized microbiome therapies, and microbiome-inspired health innovations, enabling patients to treat inhalant allergies using natural probiotic bacteria instead of synthetic steroids or antihistamines.
Contact Information
Website
www.micronose.plCorporate Office
- Ul. Energetyczna 6 / 7
- Wroclaw
- Poland
Corporate Office
- Ul. Energetyczna 6 / 7
- Wroclaw
- Poland
Micronose Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Sep-2022 | Completed | Startup |
Micronose Signals
Micronose Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| School of Pioneers | Accelerator/Incubator |
Micronose FAQs
-
When was Micronose founded?
Micronose was founded in 2022.
-
Where is Micronose headquartered?
Micronose is headquartered in Wroclaw, Poland.
-
What is the size of Micronose?
Micronose has 2 total employees.
-
What industry is Micronose in?
Micronose’s primary industry is Drug Discovery.
-
Is Micronose a private or public company?
Micronose is a Private company.
-
What is Micronose’s current revenue?
The current revenue for Micronose is .
-
Who are Micronose’s investors?
School of Pioneers has invested in Micronose.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process